Cargando…
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma
SIMPLE SUMMARY: Liver cancer is one of the most devastating human malignancies worldwide, especially in Asia, where over 70% of new cases are diagnosed. Most liver cancers are classified as hepatocellular carcinoma (HCC). HCC patients usually present at an advanced stage and have very poor prognosis...
Autores principales: | Chu, Pei-Yi, Chan, Shih-Hsuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582442/ https://www.ncbi.nlm.nih.gov/pubmed/34771459 http://dx.doi.org/10.3390/cancers13215295 |
Ejemplares similares
-
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
por: Choi, Changhoon, et al.
Publicado: (2019) -
The Cure of the "Incurable"
Publicado: (1901) -
New Lives for Old. How to Cure the Incurable
Publicado: (1935) -
Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
por: Lee, Byung Min, et al.
Publicado: (2021) -
The role of neoantigen in immune checkpoint blockade therapy
por: Yi, Ming, et al.
Publicado: (2018)